Find information on thousands of medical conditions and prescription drugs.

Trovafloxacin

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Liver Toxicity Leads FDA to Curb Trovafloxacin Use. : An article from: Family Practice News $5.95

Cardio-pulmonary medical history and the effect on clinical outcome of community-acquired pneumonia infections treated with gemifloxacin
PURPOSE: Gemifloxacin is a potent new fluoroquinolone with excellent activity against community--acquired pneumonia (CAP)pathogens. METHODS: Pooled ...
The effect of disease severity on clinical outcome with acute exacerbation of chronic bronchitis patients treated with gemifloxacin
PURPOSE: Gemifloxacin is approved to treat acute bacterial exacerbations of chronic bronchitis (AECB). Patients with AECB associated with COPD and a ...
Resistance phenotypes of streptococcus pneumoniae and clinical outcome of respiratory tract infections treated with gemifloxacin
PURPOSE: Gemifloxacin (GEM) is a potent fluoroquinolone with excellent activity against respiratory tract infection (RTI) pathogens, including S. pneumoniae ...
Comparative efficacy of oral and sequential intravenous/oral moxifloxacin in the treatment of community acquired pneumonia in the very elderly
PURPOSE: To evaluate the efficacy and safety of sequential IV/PO and PO moxifloxacin (MXF) versus that of comparator (COMP) antibiotics in very elderly ...
Adverse drug reactions in the ICU: lessons learned
The development of an adverse drug reaction (ADR) is a common occurrence in the ICU. Estimates for the incidence of ADRs in ICU patients are variable ...
Fluoroquinolones vs macrolides in the treatment of legionnaires disease
Background: Erythromycin has been the treatment of choice for Legionnaires disease (LD). However, treatment failure and experimental evidence of its ...
A New System for Moving Drugs to Market
The pharmaceutical industry is one of the most successful components of the U.S. economy. In recent years, however, critics have increasingly blamed the ...
Telithromycin for respiratory tract infections
Synopsis Telithromycin is the first member of the ketolides, a new subclass of the macrolide class of antibiotics. Its activity against common respiratory ...

Home Contact Resources Exchange Links ebay